Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genomic Characterization of HIV-Associated Plasmablastic Lymphoma Identifies Pervasive Mutations in the JAK–STAT Pathway
Zhaoqi Liu, Ioan Filip, Karen Gómez, et al.
Blood Cancer Discovery (2020) Vol. 1, Iss. 1, pp. 112-125
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Hematologic cancers in individuals infected by HIV
Antonino Carbone, Emanuela Vaccher, Annunziata Gloghini
Blood (2021) Vol. 139, Iss. 7, pp. 995-1012
Open Access | Times Cited: 83
Plasmablastic lymphoma: An update
Jenique Bailly, Nicholas Jenkins, Dharshnee Chetty, et al.
International Journal of Laboratory Hematology (2022) Vol. 44, Iss. S1, pp. 54-63
Open Access | Times Cited: 41
Plasmablastic lymphoma: 2024 update on diagnosis, risk stratification, and management
Andres Ramirez‐Gamero, Humberto Martínez‐Cordero, Brady Beltrán, et al.
American Journal of Hematology (2024) Vol. 99, Iss. 8, pp. 1586-1594
Closed Access | Times Cited: 10
MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma
Joan E. Ramis-Zaldivar, Blanca González‐Farré, Alina Nicolae, et al.
Haematologica (2021) Vol. 106, Iss. 10, pp. 2682-2693
Open Access | Times Cited: 56
Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma
Fabian Frontzek, Annette M. Staiger, Myroslav Zapukhlyak, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 32
Mutational landscape of high-grade B-cell lymphoma with <i>MYC-</i>, <i>BCL2</i> and/or <i>BCL6</i> rearrangements characterized by whole-exome sequencing
Axel Künstner, Hanno M. Witte, Jörg Riedl, et al.
Haematologica (2021) Vol. 107, Iss. 8, pp. 1850-1863
Open Access | Times Cited: 31
Genome Instability in Multiple Myeloma: Facts and Factors
Anna Y. Aksenova, Anna S. Zhuk, Artem G. Lada, et al.
Cancers (2021) Vol. 13, Iss. 23, pp. 5949-5949
Open Access | Times Cited: 30
KRAS and RAS-MAPK Pathway Deregulation in Mature B Cell Lymphoproliferative Disorders
Elena Vendramini, Riccardo Bomben, Federico Pozzo, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 666-666
Open Access | Times Cited: 21
The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma
Pietro R Di Ciaccio, Mark N. Polizzotto, Kate Cwynarski, et al.
Blood (2023) Vol. 143, Iss. 2, pp. 152-165
Open Access | Times Cited: 13
Clinical and Therapeutic Implications of Epstein–Barr Virus in HIV-Related Lymphomas
Miriam Verdú-Bou, Gustavo Tapia, Àgueda Hernández-Rodríguez, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5534-5534
Open Access | Times Cited: 26
EBV‐positive HIV‐associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic features
Jennifer R. Chapman, Alyssa Bouska, Wei Zhang, et al.
British Journal of Haematology (2021) Vol. 194, Iss. 5, pp. 870-878
Open Access | Times Cited: 25
Genetic subtyping by Whole Exome Sequencing across Diffuse Large B Cell Lymphoma and Plasmablastic Lymphoma
Aitana Avendaño Pomares, L. Merino, Sonia González, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0318689-e0318689
Open Access
Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways
Hanno M. Witte, Axel Künstner, N. Hertel, et al.
Blood Advances (2021) Vol. 6, Iss. 2, pp. 637-651
Open Access | Times Cited: 21
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1)
Michele Bibas
Mediterranean Journal of Hematology and Infectious Diseases (2024) Vol. 16, Iss. 1, pp. e2024007-e2024007
Open Access | Times Cited: 3
Characterization of the genomic landscape of HIV-associated lymphoma reveals heterogeneity across histological subtypes
Trine Engelbrecht Hybel, Emma Frasez Sørensen, Marie Hairing Enemark, et al.
AIDS (2024) Vol. 38, Iss. 14, pp. 1897-1906
Closed Access | Times Cited: 3
Towards precision medicine in lymphoid malignancies
Marco M. Bühler, José I. Martín‐Subero, Qiang Pan‐Hammarström, et al.
Journal of Internal Medicine (2021) Vol. 292, Iss. 2, pp. 221-242
Open Access | Times Cited: 19
A Comprehensive Clinicopathologic and Molecular Study of 19 Primary Effusion Lymphomas in HIV-infected Patients
Julien Calvani, Laurence Gérard, Jehane Fadlallah, et al.
The American Journal of Surgical Pathology (2021) Vol. 46, Iss. 3, pp. 353-362
Closed Access | Times Cited: 19
Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas
Rebecca J. Leeman‐Neill, Craig R. Soderquist, Francesca Montanari, et al.
Haematologica (2020) Vol. 107, Iss. 1, pp. 201-210
Open Access | Times Cited: 20
Clinicopathological and molecular features of indolent natural killer‐cell lymphoproliferative disorder of the gastrointestinal tract
Hongmei Yi, Anqi Li, Binshen Ouyang, et al.
Histopathology (2022) Vol. 82, Iss. 4, pp. 567-575
Closed Access | Times Cited: 12
Plasmablastic Lymphoma: Past, Present, and Future
Supreet Kaur, Sudarsan Kollimuttathuillam
Clinical Lymphoma Myeloma & Leukemia (2023) Vol. 23, Iss. 9, pp. e253-e259
Closed Access | Times Cited: 7
Epstein-Barr Virus and immune status imprint the immunogenomics of non-Hodgkin lymphomas occurring in immune-suppressed environments
Marine Baron, Karim Labrèche, Marianne Veyri, et al.
Haematologica (2024)
Open Access | Times Cited: 2
Plasmablastic myeloma in Taiwan frequently presents with extramedullary and extranodal mass mimicking plasmablastic lymphoma
Bo‐Jung Chen, Chang‐Tsu Yuan, Ching‐Fen Yang, et al.
Virchows Archiv (2022) Vol. 481, Iss. 2, pp. 283-293
Closed Access | Times Cited: 10
Recent advances in upper gastrointestinal lymphomas: molecular updates and diagnostic implications
Periklis Foukas, Bettina Bisig, Laurence de Leval
Histopathology (2020) Vol. 78, Iss. 1, pp. 187-214
Open Access | Times Cited: 14
Clinicopathologic and Molecular Characterization of Epstein-Barr Virus–positive Plasmacytoma
Ting Zhou, Jinjun Cheng, Jeremiah Karrs, et al.
The American Journal of Surgical Pathology (2022) Vol. 46, Iss. 10, pp. 1364-1379
Open Access | Times Cited: 9
Primary refractory plasmablastic lymphoma: A precision oncology approach
Hanno M. Witte, Anke Fähnrich, Axel Künstner, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top